Background
AZARNOFF, Daniel Lester was born on August 4, 1926 in Brooklyn, New York, United States. Son of Samuel J. and Kate (Asarnow) Azamoff.
pharmaceutical company consultant
AZARNOFF, Daniel Lester was born on August 4, 1926 in Brooklyn, New York, United States. Son of Samuel J. and Kate (Asarnow) Azamoff.
Bachelor of Science, Rutgers University, 1947; Master of Science, Rutgers University, 1948; Doctor of Medicine, U. Kansas, 1955.
Assistant instructor anatomy, U. Kansas Medical School, 1949-1950;
research fellow, U. Kansas Medical School, 1950-1952;
intern, U. Kansas Medical School, 1955-1956;
resident, National Heart Institute research fellow, U. Kansas Medical School, 1956-1958;
assistant professor medicine, U. Kansas Medical School, 1962-1964;
associate professor, U. Kansas Medical School, 1964-1968;
director clinical pharmacology study unit, U. Kansas Medical School, 1964-1968;
associate professor pharmacology, U. Kansas Medical School, 1965-1968;
professor medicine and pharmacology, U. Kansas Medical School, 1968;
director Clinical Pharmacology-Toxicology Center, U. Kansas Medical School, 1967-1978;
Distinguished professor, U. Kansas Medical School, 1973-1978;
also professor medicine, U. Kansas Medical School, 1965-1967;
president Sigma Xi Club, U. Kansas Medical School, 1968-1969;
clinical professor medicine, U. Kansas Medical School, 1982-1996;
National Institute Neurological Diseases and Blindness special trainee, Washington University School Medicine, St. Louis, 1958-1960;
assistant professor medicine, St. Saint Louis University School Medicine, 1960-1962;
visiting scientist,, Fulbright scholar Karolinska Institute, Stockholm, Sweden, 1968;
senior vice president worldwide research and development, G.D. Searle & Company, Skokie, 1978;
president, Searle Research and Development, Skokie, 1979-1985;
president, Azarnoff Associations, Inc., Evanston, Illinois, since 1986;
president, D.L. Azarnoff Associations, Southern San Francisco, California, since 1987;
professor pathology, clinical professor pharmacology, Northwestern University Medical School, 1978-1985;
commissioner, National Commision on Orphan Diseases, 1985-1987;
Chairman, Board Of Directors, Alpha RX corporation, South San Francisco, California, 1992-1994;
clinical professor medical, Stanford University School Medical, since 1998. Professorial lecturer University of Chicago, 1978-1986. Director Second Workshop on Prins.Drug Evaluation in Man, 1970.
Chairman of Commission on problems of drug safety National Research Council-NAS, 1972-1976. Board directors Oread, Inc., Lawrence, Kansas, chairman, since 1998. Chief Executive Officer Cibus Pharmaceuticals, Burlingame, California.
Consultant numerous government agys.;Chairman, Board Of Directors Cibus Pharmaceutical, Inc., 1996-1997. Board directors Entropin, Inc., De Novo, Inc., Menlo Park, California.
Served with United States Army, 1945-1946. Fellow American College of Physicians, New York Academy Sciences, American Association Pharmaceutical Scientists (Research Achievement award in clinical science 1995). Member American Society Clinical Nutrition, American Nutrition Institution, American Society Pharmacology and Experimental Therapeutics (chairman clinical pharmacology division 1969-1971, member Executive Committee 1966-1973, 78-81, delegate 1975-1978, board publication trustees), American Society Clinical Pharmacology and Therapeutics (Oscar B. Hunter Memorial award 1995), American Federation Clinical Research, British Pharmacol.
Society, American Medical Association (vice chairman county on drugs 1971-1972, editorial board journal), Control Society Clinical Research, Royal Society for Promotion Health, Institute Medicine of National Academy Sciences, Society Experimental Biology and Medicine (councillor 1976-1980), International Union Pharmacologists (secretary clin.pharmacology section 1975-1981, international advising committee Paris Congress 1978), GPIA (blue ribbon commission on generic medicine 1990), Sigma Xi.
Married Joanne Stokes, December 26, 1951. Children: Rachel, Richard, Martin.